Search

Search Results
Results 5271 - 5280 of 8190 for Skin Cancer
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Rivaroxaban-Teva intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Nolvadex (Tamoxifen citrate) intended for persons living in Australia.
  • News - 4 Sep 2024
    A recent RCT reveals the HEAL ABC intervention is feasible for 87% of colorectal cancer survivors, supporting healthy lifestyle changes and improved well-being.
  • Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Cosudex intended for persons living in Australia.
  • Drug - 2 Sep 2024
    Consumer Medicine Information (CMI) about Tevimbra intended for persons living in Australia.
  • Drug - 23 Aug 2024
    Consumer Medicine Information (CMI) about DBL Vinblastine (Vinblastine Sulfate) intended for persons living in Australia.
  • News - 2 Aug 2024
    For Lucas Farnung, there is no question more fascinating than how a single fertilized egg develops into a fully-functioning human.
  • Drug - 1 Aug 2024
    Consumer Medicine Information (CMI) about Mavenclad intended for persons living in Australia.
  • News - 21 Jul 2024
    A study in JAMA Network Open reviews evidence on massage therapy's effectiveness in relieving pain, finding moderate certainty for some conditions but overall low certainty for most.
  • Drug - 3 Jul 2024
    Consumer Medicine Information (CMI) about Ibrance tablets intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.